English
简体中文
Total: £ 56.28
Published Date: 2026-01-20 | Pages: 126 | Tables: 127 | Medical Care
The global Data-Independent Acquisition (DIA) Quantitative Proteomics market was valued at US$ 8707 million in 2025 and is anticipated to reach US$ 17170 million by 2032, at a CAGR of 10.3% from 2026 to 2032.
Data-Independent Acquisition (DIA) is a novel mass spectrometry data acquisition method developed in recent years. Current popular proteomics research techniques such as iTRAQ, TMT, Label-free, and SILAC utilize data-dependent acquisition (DDA), a method in which secondary mass spectrometry signals are collected based on the intensity of primary mass spectrometry signals. Stronger ion signals are selected for secondary acquisition, while weaker signals are discarded, resulting in the loss of secondary information from weak signals.DIA technology combines the high-throughput nature of traditional proteomics shotgun methods with the accurate quantification capabilities of the gold standard PRM (Parallel Reaction Monitoring) method. It was recognized by Nature Methods as a noteworthy technology in 2015. Presently, DIA quantitative proteomics includes two detection techniques: 3D DIA and 4D DIA. 3D DIA employs the Thermo Scientific QE series mass spectrometers, a classic choice for proteomics analysis due to its high peptide on-column loading capacity (ranging from 1-5 μg of peptides). On the other hand, 4D DIA employs the TIMS TOF mass spectrometers from Bruker, which enhances sensitivity and detection capabilities compared to the classical 3D technology, resulting in higher protein and peptide detection yields from the same sample.Data-Independent Acquisition (DIA) proteomics technology is applicable to nearly all sample types, allowing unbiased collection of all information within samples. It offers a superior solution for achieving high coverage, accuracy, and in-depth analysis of proteomes. DIA is particularly well-suited for analyzing disease-related samples rich in biological information, providing a significant resource for biomarker discovery, molecular typing, disease mechanism investigation, and more. By comparing differences in protein composition among different groups or states, this approach enables systematic studies of diseases, facilitating the development of precision therapies.
The North American market for Data-Independent Acquisition (DIA) Quantitative Proteomics is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Data-Independent Acquisition (DIA) Quantitative Proteomics is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The global market for Data-Independent Acquisition (DIA) Quantitative Proteomics in Medicine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.
Major global companies of Data-Independent Acquisition (DIA) Quantitative Proteomics include Creative Dynamics Inc (Creative Proteomics), MtoZ-Biolabs Inc., CD Genomics, AxisPharm, BGI Genomics, Metware Biotechnology Inc (Metware), OBiO Technology ( Shanghai ) Corp.,Ltd., APPLIED PROTEIN TECHNOLOGY, Novogene, Biotech Pack, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Data-Independent Acquisition (DIA) Quantitative Proteomics market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Data-Independent Acquisition (DIA) Quantitative Proteomics. The Data-Independent Acquisition (DIA) Quantitative Proteomics market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Data-Independent Acquisition (DIA) Quantitative Proteomics market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Data-Independent Acquisition (DIA) Quantitative Proteomics manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Creative Dynamics Inc (Creative Proteomics)
MtoZ-Biolabs Inc.
CD Genomics
AxisPharm
BGI Genomics
Metware Biotechnology Inc (Metware)
OBiO Technology ( Shanghai ) Corp.,Ltd.
APPLIED PROTEIN TECHNOLOGY
Novogene
Biotech Pack
SHANGHAI OE Biotech
ShangHai Biotree
JSR Corporation (Crown Bioscience)
Biomarker Technologies (BMK) GmbH
Aimsmass
Westlake Omics
WuHan RuiXing Biotechnology
GENECHEM
Wininnovate Biotechnology
Segment by Type
4D DIA
3D DIA
Segment by Application
Medicine
Plants
Animal Husbandry
Microbiology
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Data-Independent Acquisition (DIA) Quantitative Proteomics companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Data-Independent Acquisition (DIA) Quantitative Proteomics Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 4D DIA
1.2.3 3D DIA
1.3 Market by Application
1.3.1 Global Data-Independent Acquisition (DIA) Quantitative Proteomics Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Medicine
1.3.3 Plants
1.3.4 Animal Husbandry
1.3.5 Microbiology
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Data-Independent Acquisition (DIA) Quantitative Proteomics Market Perspective (2021–2032)
2.2 Global Data-Independent Acquisition (DIA) Quantitative Proteomics Growth Trends by Region
2.2.1 Global Data-Independent Acquisition (DIA) Quantitative Proteomics Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Data-Independent Acquisition (DIA) Quantitative Proteomics Historic Market Size by Region (2021–2026)
2.2.3 Data-Independent Acquisition (DIA) Quantitative Proteomics Forecasted Market Size by Region (2027–2032)
2.3 Data-Independent Acquisition (DIA) Quantitative Proteomics Market Dynamics
2.3.1 Data-Independent Acquisition (DIA) Quantitative Proteomics Industry Trends
2.3.2 Data-Independent Acquisition (DIA) Quantitative Proteomics Market Drivers
2.3.3 Data-Independent Acquisition (DIA) Quantitative Proteomics Market Challenges
2.3.4 Data-Independent Acquisition (DIA) Quantitative Proteomics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Data-Independent Acquisition (DIA) Quantitative Proteomics Players by Revenue
3.1.1 Global Top Data-Independent Acquisition (DIA) Quantitative Proteomics Players by Revenue (2021–2026)
3.1.2 Global Data-Independent Acquisition (DIA) Quantitative Proteomics Revenue Market Share by Players (2021–2026)
3.2 Global Top Data-Independent Acquisition (DIA) Quantitative Proteomics Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Data-Independent Acquisition (DIA) Quantitative Proteomics Revenue
3.4 Global Data-Independent Acquisition (DIA) Quantitative Proteomics Market Concentration Ratio
3.4.1 Global Data-Independent Acquisition (DIA) Quantitative Proteomics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Data-Independent Acquisition (DIA) Quantitative Proteomics Revenue in 2025
3.5 Global Key Players of Data-Independent Acquisition (DIA) Quantitative Proteomics Head Offices and Areas Served
3.6 Global Key Players of Data-Independent Acquisition (DIA) Quantitative Proteomics, Products and Applications
3.7 Global Key Players of Data-Independent Acquisition (DIA) Quantitative Proteomics, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Data-Independent Acquisition (DIA) Quantitative Proteomics Breakdown Data by Type
4.1 Global Data-Independent Acquisition (DIA) Quantitative Proteomics Historic Market Size by Type (2021–2026)
4.2 Global Data-Independent Acquisition (DIA) Quantitative Proteomics Forecasted Market Size by Type (2027–2032)
5 Data-Independent Acquisition (DIA) Quantitative Proteomics Breakdown Data by Application
5.1 Global Data-Independent Acquisition (DIA) Quantitative Proteomics Historic Market Size by Application (2021–2026)
5.2 Global Data-Independent Acquisition (DIA) Quantitative Proteomics Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Data-Independent Acquisition (DIA) Quantitative Proteomics Market Size (2021–2032)
6.2 North America Data-Independent Acquisition (DIA) Quantitative Proteomics Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Data-Independent Acquisition (DIA) Quantitative Proteomics Market Size by Country (2021–2026)
6.4 North America Data-Independent Acquisition (DIA) Quantitative Proteomics Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Data-Independent Acquisition (DIA) Quantitative Proteomics Market Size (2021–2032)
7.2 Europe Data-Independent Acquisition (DIA) Quantitative Proteomics Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Data-Independent Acquisition (DIA) Quantitative Proteomics Market Size by Country (2021–2026)
7.4 Europe Data-Independent Acquisition (DIA) Quantitative Proteomics Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Data-Independent Acquisition (DIA) Quantitative Proteomics Market Size (2021–2032)
8.2 Asia-Pacific Data-Independent Acquisition (DIA) Quantitative Proteomics Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Data-Independent Acquisition (DIA) Quantitative Proteomics Market Size by Region (2021–2026)
8.4 Asia-Pacific Data-Independent Acquisition (DIA) Quantitative Proteomics Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Data-Independent Acquisition (DIA) Quantitative Proteomics Market Size (2021–2032)
9.2 Latin America Data-Independent Acquisition (DIA) Quantitative Proteomics Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Data-Independent Acquisition (DIA) Quantitative Proteomics Market Size by Country (2021–2026)
9.4 Latin America Data-Independent Acquisition (DIA) Quantitative Proteomics Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Data-Independent Acquisition (DIA) Quantitative Proteomics Market Size (2021–2032)
10.2 Middle East & Africa Data-Independent Acquisition (DIA) Quantitative Proteomics Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Data-Independent Acquisition (DIA) Quantitative Proteomics Market Size by Country (2021–2026)
10.4 Middle East & Africa Data-Independent Acquisition (DIA) Quantitative Proteomics Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Creative Dynamics Inc (Creative Proteomics)
11.1.1 Creative Dynamics Inc (Creative Proteomics) Company Details
11.1.2 Creative Dynamics Inc (Creative Proteomics) Business Overview
11.1.3 Creative Dynamics Inc (Creative Proteomics) Data-Independent Acquisition (DIA) Quantitative Proteomics Introduction
11.1.4 Creative Dynamics Inc (Creative Proteomics) Revenue in Data-Independent Acquisition (DIA) Quantitative Proteomics Business (2021–2026)
11.1.5 Creative Dynamics Inc (Creative Proteomics) Recent Development
11.2 MtoZ-Biolabs Inc.
11.2.1 MtoZ-Biolabs Inc. Company Details
11.2.2 MtoZ-Biolabs Inc. Business Overview
11.2.3 MtoZ-Biolabs Inc. Data-Independent Acquisition (DIA) Quantitative Proteomics Introduction
11.2.4 MtoZ-Biolabs Inc. Revenue in Data-Independent Acquisition (DIA) Quantitative Proteomics Business (2021–2026)
11.2.5 MtoZ-Biolabs Inc. Recent Development
11.3 CD Genomics
11.3.1 CD Genomics Company Details
11.3.2 CD Genomics Business Overview
11.3.3 CD Genomics Data-Independent Acquisition (DIA) Quantitative Proteomics Introduction
11.3.4 CD Genomics Revenue in Data-Independent Acquisition (DIA) Quantitative Proteomics Business (2021–2026)
11.3.5 CD Genomics Recent Development
11.4 AxisPharm
11.4.1 AxisPharm Company Details
11.4.2 AxisPharm Business Overview
11.4.3 AxisPharm Data-Independent Acquisition (DIA) Quantitative Proteomics Introduction
11.4.4 AxisPharm Revenue in Data-Independent Acquisition (DIA) Quantitative Proteomics Business (2021–2026)
11.4.5 AxisPharm Recent Development
11.5 BGI Genomics
11.5.1 BGI Genomics Company Details
11.5.2 BGI Genomics Business Overview
11.5.3 BGI Genomics Data-Independent Acquisition (DIA) Quantitative Proteomics Introduction
11.5.4 BGI Genomics Revenue in Data-Independent Acquisition (DIA) Quantitative Proteomics Business (2021–2026)
11.5.5 BGI Genomics Recent Development
11.6 Metware Biotechnology Inc (Metware)
11.6.1 Metware Biotechnology Inc (Metware) Company Details
11.6.2 Metware Biotechnology Inc (Metware) Business Overview
11.6.3 Metware Biotechnology Inc (Metware) Data-Independent Acquisition (DIA) Quantitative Proteomics Introduction
11.6.4 Metware Biotechnology Inc (Metware) Revenue in Data-Independent Acquisition (DIA) Quantitative Proteomics Business (2021–2026)
11.6.5 Metware Biotechnology Inc (Metware) Recent Development
11.7 OBiO Technology ( Shanghai ) Corp.,Ltd.
11.7.1 OBiO Technology ( Shanghai ) Corp.,Ltd. Company Details
11.7.2 OBiO Technology ( Shanghai ) Corp.,Ltd. Business Overview
11.7.3 OBiO Technology ( Shanghai ) Corp.,Ltd. Data-Independent Acquisition (DIA) Quantitative Proteomics Introduction
11.7.4 OBiO Technology ( Shanghai ) Corp.,Ltd. Revenue in Data-Independent Acquisition (DIA) Quantitative Proteomics Business (2021–2026)
11.7.5 OBiO Technology ( Shanghai ) Corp.,Ltd. Recent Development
11.8 APPLIED PROTEIN TECHNOLOGY
11.8.1 APPLIED PROTEIN TECHNOLOGY Company Details
11.8.2 APPLIED PROTEIN TECHNOLOGY Business Overview
11.8.3 APPLIED PROTEIN TECHNOLOGY Data-Independent Acquisition (DIA) Quantitative Proteomics Introduction
11.8.4 APPLIED PROTEIN TECHNOLOGY Revenue in Data-Independent Acquisition (DIA) Quantitative Proteomics Business (2021–2026)
11.8.5 APPLIED PROTEIN TECHNOLOGY Recent Development
11.9 Novogene
11.9.1 Novogene Company Details
11.9.2 Novogene Business Overview
11.9.3 Novogene Data-Independent Acquisition (DIA) Quantitative Proteomics Introduction
11.9.4 Novogene Revenue in Data-Independent Acquisition (DIA) Quantitative Proteomics Business (2021–2026)
11.9.5 Novogene Recent Development
11.10 Biotech Pack
11.10.1 Biotech Pack Company Details
11.10.2 Biotech Pack Business Overview
11.10.3 Biotech Pack Data-Independent Acquisition (DIA) Quantitative Proteomics Introduction
11.10.4 Biotech Pack Revenue in Data-Independent Acquisition (DIA) Quantitative Proteomics Business (2021–2026)
11.10.5 Biotech Pack Recent Development
11.11 SHANGHAI OE Biotech
11.11.1 SHANGHAI OE Biotech Company Details
11.11.2 SHANGHAI OE Biotech Business Overview
11.11.3 SHANGHAI OE Biotech Data-Independent Acquisition (DIA) Quantitative Proteomics Introduction
11.11.4 SHANGHAI OE Biotech Revenue in Data-Independent Acquisition (DIA) Quantitative Proteomics Business (2021–2026)
11.11.5 SHANGHAI OE Biotech Recent Development
11.12 ShangHai Biotree
11.12.1 ShangHai Biotree Company Details
11.12.2 ShangHai Biotree Business Overview
11.12.3 ShangHai Biotree Data-Independent Acquisition (DIA) Quantitative Proteomics Introduction
11.12.4 ShangHai Biotree Revenue in Data-Independent Acquisition (DIA) Quantitative Proteomics Business (2021–2026)
11.12.5 ShangHai Biotree Recent Development
11.13 JSR Corporation (Crown Bioscience)
11.13.1 JSR Corporation (Crown Bioscience) Company Details
11.13.2 JSR Corporation (Crown Bioscience) Business Overview
11.13.3 JSR Corporation (Crown Bioscience) Data-Independent Acquisition (DIA) Quantitative Proteomics Introduction
11.13.4 JSR Corporation (Crown Bioscience) Revenue in Data-Independent Acquisition (DIA) Quantitative Proteomics Business (2021–2026)
11.13.5 JSR Corporation (Crown Bioscience) Recent Development
11.14 Biomarker Technologies (BMK) GmbH
11.14.1 Biomarker Technologies (BMK) GmbH Company Details
11.14.2 Biomarker Technologies (BMK) GmbH Business Overview
11.14.3 Biomarker Technologies (BMK) GmbH Data-Independent Acquisition (DIA) Quantitative Proteomics Introduction
11.14.4 Biomarker Technologies (BMK) GmbH Revenue in Data-Independent Acquisition (DIA) Quantitative Proteomics Business (2021–2026)
11.14.5 Biomarker Technologies (BMK) GmbH Recent Development
11.15 Aimsmass
11.15.1 Aimsmass Company Details
11.15.2 Aimsmass Business Overview
11.15.3 Aimsmass Data-Independent Acquisition (DIA) Quantitative Proteomics Introduction
11.15.4 Aimsmass Revenue in Data-Independent Acquisition (DIA) Quantitative Proteomics Business (2021–2026)
11.15.5 Aimsmass Recent Development
11.16 Westlake Omics
11.16.1 Westlake Omics Company Details
11.16.2 Westlake Omics Business Overview
11.16.3 Westlake Omics Data-Independent Acquisition (DIA) Quantitative Proteomics Introduction
11.16.4 Westlake Omics Revenue in Data-Independent Acquisition (DIA) Quantitative Proteomics Business (2021–2026)
11.16.5 Westlake Omics Recent Development
11.17 WuHan RuiXing Biotechnology
11.17.1 WuHan RuiXing Biotechnology Company Details
11.17.2 WuHan RuiXing Biotechnology Business Overview
11.17.3 WuHan RuiXing Biotechnology Data-Independent Acquisition (DIA) Quantitative Proteomics Introduction
11.17.4 WuHan RuiXing Biotechnology Revenue in Data-Independent Acquisition (DIA) Quantitative Proteomics Business (2021–2026)
11.17.5 WuHan RuiXing Biotechnology Recent Development
11.18 GENECHEM
11.18.1 GENECHEM Company Details
11.18.2 GENECHEM Business Overview
11.18.3 GENECHEM Data-Independent Acquisition (DIA) Quantitative Proteomics Introduction
11.18.4 GENECHEM Revenue in Data-Independent Acquisition (DIA) Quantitative Proteomics Business (2021–2026)
11.18.5 GENECHEM Recent Development
11.19 Wininnovate Biotechnology
11.19.1 Wininnovate Biotechnology Company Details
11.19.2 Wininnovate Biotechnology Business Overview
11.19.3 Wininnovate Biotechnology Data-Independent Acquisition (DIA) Quantitative Proteomics Introduction
11.19.4 Wininnovate Biotechnology Revenue in Data-Independent Acquisition (DIA) Quantitative Proteomics Business (2021–2026)
11.19.5 Wininnovate Biotechnology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Data-Independent Acquisition (DIA) Quantitative Proteomics Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of 4D DIA
Table 3. Key Players of 3D DIA
Table 4. Global Data-Independent Acquisition (DIA) Quantitative Proteomics Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 5. Global Data-Independent Acquisition (DIA) Quantitative Proteomics Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Data-Independent Acquisition (DIA) Quantitative Proteomics Market Size by Region (US$ Million), 2021–2026
Table 7. Global Data-Independent Acquisition (DIA) Quantitative Proteomics Market Share by Region (2021–2026)
Table 8. Global Data-Independent Acquisition (DIA) Quantitative Proteomics Forecasted Market Size by Region (US$ Million), 2027–2032
Table 9. Global Data-Independent Acquisition (DIA) Quantitative Proteomics Market Share by Region (2027–2032)
Table 10. Data-Independent Acquisition (DIA) Quantitative Proteomics Market Trends
Table 11. Data-Independent Acquisition (DIA) Quantitative Proteomics Market Drivers
Table 12. Data-Independent Acquisition (DIA) Quantitative Proteomics Market Challenges
Table 13. Data-Independent Acquisition (DIA) Quantitative Proteomics Market Restraints
Table 14. Global Data-Independent Acquisition (DIA) Quantitative Proteomics Revenue by Players (US$ Million), 2021–2026
Table 15. Global Data-Independent Acquisition (DIA) Quantitative Proteomics Market Share by Players (2021–2026)
Table 16. Global Top Data-Independent Acquisition (DIA) Quantitative Proteomics Players by Tier (Tier 1, Tier 2, and Tier 3), based on Data-Independent Acquisition (DIA) Quantitative Proteomics Revenue, 2025
Table 17. Ranking of Global Top Data-Independent Acquisition (DIA) Quantitative Proteomics Companies by Revenue (US$ Million) in 2025
Table 18. Global 5 Largest Players Market Share by Data-Independent Acquisition (DIA) Quantitative Proteomics Revenue (CR5 and HHI), 2021–2026
Table 19. Global Key Players of Data-Independent Acquisition (DIA) Quantitative Proteomics, Headquarters and Area Served
Table 20. Global Key Players of Data-Independent Acquisition (DIA) Quantitative Proteomics, Products and Applications
Table 21. Global Key Players of Data-Independent Acquisition (DIA) Quantitative Proteomics, Date of General Availability (GA)
Table 22. Mergers and Acquisitions, Expansion Plans
Table 23. Global Data-Independent Acquisition (DIA) Quantitative Proteomics Market Size by Type (US$ Million), 2021–2026
Table 24. Global Data-Independent Acquisition (DIA) Quantitative Proteomics Revenue Market Share by Type (2021–2026)
Table 25. Global Data-Independent Acquisition (DIA) Quantitative Proteomics Forecasted Market Size by Type (US$ Million), 2027–2032
Table 26. Global Data-Independent Acquisition (DIA) Quantitative Proteomics Revenue Market Share by Type (2027–2032)
Table 27. Global Data-Independent Acquisition (DIA) Quantitative Proteomics Market Size by Application (US$ Million), 2021–2026
Table 28. Global Data-Independent Acquisition (DIA) Quantitative Proteomics Revenue Market Share by Application (2021–2026)
Table 29. Global Data-Independent Acquisition (DIA) Quantitative Proteomics Forecasted Market Size by Application (US$ Million), 2027–2032
Table 30. Global Data-Independent Acquisition (DIA) Quantitative Proteomics Revenue Market Share by Application (2027–2032)
Table 31. North America Data-Independent Acquisition (DIA) Quantitative Proteomics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 32. North America Data-Independent Acquisition (DIA) Quantitative Proteomics Market Size by Country (US$ Million), 2021–2026
Table 33. North America Data-Independent Acquisition (DIA) Quantitative Proteomics Market Size by Country (US$ Million), 2027–2032
Table 34. Europe Data-Independent Acquisition (DIA) Quantitative Proteomics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 35. Europe Data-Independent Acquisition (DIA) Quantitative Proteomics Market Size by Country (US$ Million), 2021–2026
Table 36. Europe Data-Independent Acquisition (DIA) Quantitative Proteomics Market Size by Country (US$ Million), 2027–2032
Table 37. Asia-Pacific Data-Independent Acquisition (DIA) Quantitative Proteomics Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 38. Asia-Pacific Data-Independent Acquisition (DIA) Quantitative Proteomics Market Size by Region (US$ Million), 2021–2026
Table 39. Asia-Pacific Data-Independent Acquisition (DIA) Quantitative Proteomics Market Size by Region (US$ Million), 2027–2032
Table 40. Latin America Data-Independent Acquisition (DIA) Quantitative Proteomics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 41. Latin America Data-Independent Acquisition (DIA) Quantitative Proteomics Market Size by Country (US$ Million), 2021–2026
Table 42. Latin America Data-Independent Acquisition (DIA) Quantitative Proteomics Market Size by Country (US$ Million), 2027–2032
Table 43. Middle East & Africa Data-Independent Acquisition (DIA) Quantitative Proteomics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 44. Middle East & Africa Data-Independent Acquisition (DIA) Quantitative Proteomics Market Size by Country (US$ Million), 2021–2026
Table 45. Middle East & Africa Data-Independent Acquisition (DIA) Quantitative Proteomics Market Size by Country (US$ Million), 2027–2032
Table 46. Creative Dynamics Inc (Creative Proteomics) Company Details
Table 47. Creative Dynamics Inc (Creative Proteomics) Business Overview
Table 48. Creative Dynamics Inc (Creative Proteomics) Data-Independent Acquisition (DIA) Quantitative Proteomics Product
Table 49. Creative Dynamics Inc (Creative Proteomics) Revenue in Data-Independent Acquisition (DIA) Quantitative Proteomics Business (US$ Million), 2021–2026
Table 50. Creative Dynamics Inc (Creative Proteomics) Recent Development
Table 51. MtoZ-Biolabs Inc. Company Details
Table 52. MtoZ-Biolabs Inc. Business Overview
Table 53. MtoZ-Biolabs Inc. Data-Independent Acquisition (DIA) Quantitative Proteomics Product
Table 54. MtoZ-Biolabs Inc. Revenue in Data-Independent Acquisition (DIA) Quantitative Proteomics Business (US$ Million), 2021–2026
Table 55. MtoZ-Biolabs Inc. Recent Development
Table 56. CD Genomics Company Details
Table 57. CD Genomics Business Overview
Table 58. CD Genomics Data-Independent Acquisition (DIA) Quantitative Proteomics Product
Table 59. CD Genomics Revenue in Data-Independent Acquisition (DIA) Quantitative Proteomics Business (US$ Million), 2021–2026
Table 60. CD Genomics Recent Development
Table 61. AxisPharm Company Details
Table 62. AxisPharm Business Overview
Table 63. AxisPharm Data-Independent Acquisition (DIA) Quantitative Proteomics Product
Table 64. AxisPharm Revenue in Data-Independent Acquisition (DIA) Quantitative Proteomics Business (US$ Million), 2021–2026
Table 65. AxisPharm Recent Development
Table 66. BGI Genomics Company Details
Table 67. BGI Genomics Business Overview
Table 68. BGI Genomics Data-Independent Acquisition (DIA) Quantitative Proteomics Product
Table 69. BGI Genomics Revenue in Data-Independent Acquisition (DIA) Quantitative Proteomics Business (US$ Million), 2021–2026
Table 70. BGI Genomics Recent Development
Table 71. Metware Biotechnology Inc (Metware) Company Details
Table 72. Metware Biotechnology Inc (Metware) Business Overview
Table 73. Metware Biotechnology Inc (Metware) Data-Independent Acquisition (DIA) Quantitative Proteomics Product
Table 74. Metware Biotechnology Inc (Metware) Revenue in Data-Independent Acquisition (DIA) Quantitative Proteomics Business (US$ Million), 2021–2026
Table 75. Metware Biotechnology Inc (Metware) Recent Development
Table 76. OBiO Technology ( Shanghai ) Corp.,Ltd. Company Details
Table 77. OBiO Technology ( Shanghai ) Corp.,Ltd. Business Overview
Table 78. OBiO Technology ( Shanghai ) Corp.,Ltd. Data-Independent Acquisition (DIA) Quantitative Proteomics Product
Table 79. OBiO Technology ( Shanghai ) Corp.,Ltd. Revenue in Data-Independent Acquisition (DIA) Quantitative Proteomics Business (US$ Million), 2021–2026
Table 80. OBiO Technology ( Shanghai ) Corp.,Ltd. Recent Development
Table 81. APPLIED PROTEIN TECHNOLOGY Company Details
Table 82. APPLIED PROTEIN TECHNOLOGY Business Overview
Table 83. APPLIED PROTEIN TECHNOLOGY Data-Independent Acquisition (DIA) Quantitative Proteomics Product
Table 84. APPLIED PROTEIN TECHNOLOGY Revenue in Data-Independent Acquisition (DIA) Quantitative Proteomics Business (US$ Million), 2021–2026
Table 85. APPLIED PROTEIN TECHNOLOGY Recent Development
Table 86. Novogene Company Details
Table 87. Novogene Business Overview
Table 88. Novogene Data-Independent Acquisition (DIA) Quantitative Proteomics Product
Table 89. Novogene Revenue in Data-Independent Acquisition (DIA) Quantitative Proteomics Business (US$ Million), 2021–2026
Table 90. Novogene Recent Development
Table 91. Biotech Pack Company Details
Table 92. Biotech Pack Business Overview
Table 93. Biotech Pack Data-Independent Acquisition (DIA) Quantitative Proteomics Product
Table 94. Biotech Pack Revenue in Data-Independent Acquisition (DIA) Quantitative Proteomics Business (US$ Million), 2021–2026
Table 95. Biotech Pack Recent Development
Table 96. SHANGHAI OE Biotech Company Details
Table 97. SHANGHAI OE Biotech Business Overview
Table 98. SHANGHAI OE Biotech Data-Independent Acquisition (DIA) Quantitative Proteomics Product
Table 99. SHANGHAI OE Biotech Revenue in Data-Independent Acquisition (DIA) Quantitative Proteomics Business (US$ Million), 2021–2026
Table 100. SHANGHAI OE Biotech Recent Development
Table 101. ShangHai Biotree Company Details
Table 102. ShangHai Biotree Business Overview
Table 103. ShangHai Biotree Data-Independent Acquisition (DIA) Quantitative Proteomics Product
Table 104. ShangHai Biotree Revenue in Data-Independent Acquisition (DIA) Quantitative Proteomics Business (US$ Million), 2021–2026
Table 105. ShangHai Biotree Recent Development
Table 106. JSR Corporation (Crown Bioscience) Company Details
Table 107. JSR Corporation (Crown Bioscience) Business Overview
Table 108. JSR Corporation (Crown Bioscience) Data-Independent Acquisition (DIA) Quantitative Proteomics Product
Table 109. JSR Corporation (Crown Bioscience) Revenue in Data-Independent Acquisition (DIA) Quantitative Proteomics Business (US$ Million), 2021–2026
Table 110. JSR Corporation (Crown Bioscience) Recent Development
Table 111. Biomarker Technologies (BMK) GmbH Company Details
Table 112. Biomarker Technologies (BMK) GmbH Business Overview
Table 113. Biomarker Technologies (BMK) GmbH Data-Independent Acquisition (DIA) Quantitative Proteomics Product
Table 114. Biomarker Technologies (BMK) GmbH Revenue in Data-Independent Acquisition (DIA) Quantitative Proteomics Business (US$ Million), 2021–2026
Table 115. Biomarker Technologies (BMK) GmbH Recent Development
Table 116. Aimsmass Company Details
Table 117. Aimsmass Business Overview
Table 118. Aimsmass Data-Independent Acquisition (DIA) Quantitative Proteomics Product
Table 119. Aimsmass Revenue in Data-Independent Acquisition (DIA) Quantitative Proteomics Business (US$ Million), 2021–2026
Table 120. Aimsmass Recent Development
Table 121. Westlake Omics Company Details
Table 122. Westlake Omics Business Overview
Table 123. Westlake Omics Data-Independent Acquisition (DIA) Quantitative Proteomics Product
Table 124. Westlake Omics Revenue in Data-Independent Acquisition (DIA) Quantitative Proteomics Business (US$ Million), 2021–2026
Table 125. Westlake Omics Recent Development
Table 126. WuHan RuiXing Biotechnology Company Details
Table 127. WuHan RuiXing Biotechnology Business Overview
Table 128. WuHan RuiXing Biotechnology Data-Independent Acquisition (DIA) Quantitative Proteomics Product
Table 129. WuHan RuiXing Biotechnology Revenue in Data-Independent Acquisition (DIA) Quantitative Proteomics Business (US$ Million), 2021–2026
Table 130. WuHan RuiXing Biotechnology Recent Development
Table 131. GENECHEM Company Details
Table 132. GENECHEM Business Overview
Table 133. GENECHEM Data-Independent Acquisition (DIA) Quantitative Proteomics Product
Table 134. GENECHEM Revenue in Data-Independent Acquisition (DIA) Quantitative Proteomics Business (US$ Million), 2021–2026
Table 135. GENECHEM Recent Development
Table 136. Wininnovate Biotechnology Company Details
Table 137. Wininnovate Biotechnology Business Overview
Table 138. Wininnovate Biotechnology Data-Independent Acquisition (DIA) Quantitative Proteomics Product
Table 139. Wininnovate Biotechnology Revenue in Data-Independent Acquisition (DIA) Quantitative Proteomics Business (US$ Million), 2021–2026
Table 140. Wininnovate Biotechnology Recent Development
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
Table 144. Authors List of This Report
List of Figures
Figure 1. Data-Independent Acquisition (DIA) Quantitative Proteomics Picture
Figure 2. Global Data-Independent Acquisition (DIA) Quantitative Proteomics Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Data-Independent Acquisition (DIA) Quantitative Proteomics Market Share by Type: 2025 vs 2032
Figure 4. 4D DIA Features
Figure 5. 3D DIA Features
Figure 6. Global Data-Independent Acquisition (DIA) Quantitative Proteomics Market Size by Application (US$ Million), 2021–2032
Figure 7. Global Data-Independent Acquisition (DIA) Quantitative Proteomics Market Share by Application: 2025 vs 2032
Figure 8. Medicine Case Studies
Figure 9. Plants Case Studies
Figure 10. Animal Husbandry Case Studies
Figure 11. Microbiology Case Studies
Figure 12. Data-Independent Acquisition (DIA) Quantitative Proteomics Report Years Considered
Figure 13. Global Data-Independent Acquisition (DIA) Quantitative Proteomics Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 14. Global Data-Independent Acquisition (DIA) Quantitative Proteomics Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 15. Global Data-Independent Acquisition (DIA) Quantitative Proteomics Market Share by Region: 2025 vs 2032
Figure 16. Global Data-Independent Acquisition (DIA) Quantitative Proteomics Market Share by Players in 2025
Figure 17. Global Data-Independent Acquisition (DIA) Quantitative Proteomics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 18. The Top 10 and 5 Players Market Share by Data-Independent Acquisition (DIA) Quantitative Proteomics Revenue in 2025
Figure 19. North America Data-Independent Acquisition (DIA) Quantitative Proteomics Market Size YoY Growth (US$ Million), 2021–2032
Figure 20. North America Data-Independent Acquisition (DIA) Quantitative Proteomics Market Share by Country (2021–2032)
Figure 21. United States Data-Independent Acquisition (DIA) Quantitative Proteomics Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. Canada Data-Independent Acquisition (DIA) Quantitative Proteomics Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Europe Data-Independent Acquisition (DIA) Quantitative Proteomics Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Europe Data-Independent Acquisition (DIA) Quantitative Proteomics Market Share by Country (2021–2032)
Figure 25. Germany Data-Independent Acquisition (DIA) Quantitative Proteomics Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. France Data-Independent Acquisition (DIA) Quantitative Proteomics Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. U.K. Data-Independent Acquisition (DIA) Quantitative Proteomics Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Italy Data-Independent Acquisition (DIA) Quantitative Proteomics Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Russia Data-Independent Acquisition (DIA) Quantitative Proteomics Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Ireland Data-Independent Acquisition (DIA) Quantitative Proteomics Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Asia-Pacific Data-Independent Acquisition (DIA) Quantitative Proteomics Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Asia-Pacific Data-Independent Acquisition (DIA) Quantitative Proteomics Market Share by Region (2021–2032)
Figure 33. China Data-Independent Acquisition (DIA) Quantitative Proteomics Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Japan Data-Independent Acquisition (DIA) Quantitative Proteomics Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. South Korea Data-Independent Acquisition (DIA) Quantitative Proteomics Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Southeast Asia Data-Independent Acquisition (DIA) Quantitative Proteomics Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. India Data-Independent Acquisition (DIA) Quantitative Proteomics Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Australia & New Zealand Data-Independent Acquisition (DIA) Quantitative Proteomics Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Latin America Data-Independent Acquisition (DIA) Quantitative Proteomics Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Latin America Data-Independent Acquisition (DIA) Quantitative Proteomics Market Share by Country (2021–2032)
Figure 41. Mexico Data-Independent Acquisition (DIA) Quantitative Proteomics Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Brazil Data-Independent Acquisition (DIA) Quantitative Proteomics Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Middle East & Africa Data-Independent Acquisition (DIA) Quantitative Proteomics Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Middle East & Africa Data-Independent Acquisition (DIA) Quantitative Proteomics Market Share by Country (2021–2032)
Figure 45. Israel Data-Independent Acquisition (DIA) Quantitative Proteomics Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Saudi Arabia Data-Independent Acquisition (DIA) Quantitative Proteomics Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. UAE Data-Independent Acquisition (DIA) Quantitative Proteomics Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. Creative Dynamics Inc (Creative Proteomics) Revenue Growth Rate in Data-Independent Acquisition (DIA) Quantitative Proteomics Business (2021–2026)
Figure 49. MtoZ-Biolabs Inc. Revenue Growth Rate in Data-Independent Acquisition (DIA) Quantitative Proteomics Business (2021–2026)
Figure 50. CD Genomics Revenue Growth Rate in Data-Independent Acquisition (DIA) Quantitative Proteomics Business (2021–2026)
Figure 51. AxisPharm Revenue Growth Rate in Data-Independent Acquisition (DIA) Quantitative Proteomics Business (2021–2026)
Figure 52. BGI Genomics Revenue Growth Rate in Data-Independent Acquisition (DIA) Quantitative Proteomics Business (2021–2026)
Figure 53. Metware Biotechnology Inc (Metware) Revenue Growth Rate in Data-Independent Acquisition (DIA) Quantitative Proteomics Business (2021–2026)
Figure 54. OBiO Technology ( Shanghai ) Corp.,Ltd. Revenue Growth Rate in Data-Independent Acquisition (DIA) Quantitative Proteomics Business (2021–2026)
Figure 55. APPLIED PROTEIN TECHNOLOGY Revenue Growth Rate in Data-Independent Acquisition (DIA) Quantitative Proteomics Business (2021–2026)
Figure 56. Novogene Revenue Growth Rate in Data-Independent Acquisition (DIA) Quantitative Proteomics Business (2021–2026)
Figure 57. Biotech Pack Revenue Growth Rate in Data-Independent Acquisition (DIA) Quantitative Proteomics Business (2021–2026)
Figure 58. SHANGHAI OE Biotech Revenue Growth Rate in Data-Independent Acquisition (DIA) Quantitative Proteomics Business (2021–2026)
Figure 59. ShangHai Biotree Revenue Growth Rate in Data-Independent Acquisition (DIA) Quantitative Proteomics Business (2021–2026)
Figure 60. JSR Corporation (Crown Bioscience) Revenue Growth Rate in Data-Independent Acquisition (DIA) Quantitative Proteomics Business (2021–2026)
Figure 61. Biomarker Technologies (BMK) GmbH Revenue Growth Rate in Data-Independent Acquisition (DIA) Quantitative Proteomics Business (2021–2026)
Figure 62. Aimsmass Revenue Growth Rate in Data-Independent Acquisition (DIA) Quantitative Proteomics Business (2021–2026)
Figure 63. Westlake Omics Revenue Growth Rate in Data-Independent Acquisition (DIA) Quantitative Proteomics Business (2021–2026)
Figure 64. WuHan RuiXing Biotechnology Revenue Growth Rate in Data-Independent Acquisition (DIA) Quantitative Proteomics Business (2021–2026)
Figure 65. GENECHEM Revenue Growth Rate in Data-Independent Acquisition (DIA) Quantitative Proteomics Business (2021–2026)
Figure 66. Wininnovate Biotechnology Revenue Growth Rate in Data-Independent Acquisition (DIA) Quantitative Proteomics Business (2021–2026)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
